Evidence map›Paper›PMID 30355154›Full record

ReviewAnnual review of pathology2019

Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection.

Wei Gu, Steve Miller, Charles Y Chiu

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Annual review of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 917 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
917citing papers in PubMed, 1 pooled it
28.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04034264 recruitingnot on this map

Characterization of Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2019 to 2027Enrolled6,500ConditionsVector-Borne Diseases, Emerging Pathogens
NCT05085158 unknown statusnot on this mapstarted 2023, after this paper: background citation

Pathogen Detection in HIV-infected Children and Adolescents With Non-malarial Febrile Illnesses Using Metagenomic Next-generation Sequencing Approach in Uganda

TypeobservationalSponsorMakerere UniversityRan2023 to 2024Enrolled138ConditionsHIV Infection
3 · Its place in the literature

Who cites it

917 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,381 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. First case of neonatal bloodstream infection caused byExperimental and therapeutic medicine · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Clinical utility of metagenomic next-generation sequencing in precision diagnosis of infectious diseases: a retrospective study based on bronchoalveolar lavage fluid, blood, and cerebrospinal fluid.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  13. Prognosis of Patients Infected WithJournal of general and family medicine · 2026
    Article
  14. Article
  15. Review
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

857 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wei GuDepartment of Laboratory Medicine, University of California, San Francisco, California 94107, USA; email: Charles.Chiu@ucsf.edu.
Steve MillerDepartment of Laboratory Medicine, University of California, San Francisco, California 94107, USA; email: Charles.Chiu@ucsf.edu.
Charles Y ChiuDepartment of Laboratory Medicine, University of California, San Francisco, California 94107, USA; email: Charles.Chiu@ucsf.edu.
University of California, San Francisco · US

Funding

Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious AgentsR01HL105704 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2011 to 2020
$5.9M
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore SequencingR33AI120977 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2018 to 2020
$1.6M
Noninvasive Risk Stratification of Prostate Cancer Using Cell-Free Nucleic AcidsK08CA230156 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GU, WEI · 2018 to 2022
$1.4M
NCI NIH HHS K08 CA230156NHLBI NIH HHS R01 HL105704NIAID NIH HHS R33 AI120977
6 · The paper itself

Abstract

Nearly all infectious agents contain DNA or RNA genomes, making sequencing an attractive approach for pathogen detection. The cost of high-throughput or next-generation sequencing has been reduced by several orders of magnitude since its advent in 2004, and it has emerged as an enabling technological platform for the detection and taxonomic characterization of microorganisms in clinical samples from patients. This review focuses on the application of untargeted metagenomic next-generation sequencing to the clinical diagnosis of infectious diseases, particularly in areas in which conventional diagnostic approaches have limitations. The review covers ( a) next-generation sequencing technologies and common platforms, ( b) next-generation sequencing assay workflows in the clinical microbiology laboratory, ( c) bioinformatics analysis of metagenomic next-generation sequencing data, ( d) validation and use of metagenomic next-generation sequencing for diagnosing infectious diseases, and ( e) significant case reports and studies in this area. Next-generation sequencing is a new technology that has the promise to enhance our ability to diagnose, interrogate, and track infectious diseases.

Indexed as

Communicable DiseasesHigh-Throughput Nucleotide SequencingHumansMetagenomeMetagenomicsSequence Analysis, DNASequence Analysis, RNAclinical diagnosticsinfectious diseasemetagenomicsnanopore sequencingnext-generation sequencingpathogen detection

Identifiers

PMID30355154
PMCPMC6345613
OpenAlexW2898604559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.